ChroMedX Corp. Awarded Two New Patents on Ultra-Filtration Technology

September 30, 2015 4:12 PM

TORONTO, ON / ACCESSWIRE / September 30, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded two additional Canadian patents on its Automated Ultra Filtration (AUF) technology. These patents demonstrate the novelty, inventiveness and usefulness of the AUF technology, and are listed below: 1. CA...

Read more

True Leaf Launches Healthy Hemp Chews for Dogs

September 17, 2015 3:26 AM

LOS ANGELES, CA / ACCESSWIRE / September 17, 2015 / An exciting array of new products will be unveiled today by True Leaf Medicine International Ltd., (CNSX: MJ) (FSE: TLA) ("True Leaf" or the "company") at the Cannabis World Conference and Business Expo in LA. They're an innovative line of chews for dogs featuring hemp and other plant-based active ingredients to provide joint, calming and antioxidant support for dogs. Trio of products to...

Read more

ChroMedX Callaborates with Biointerfaces Institute and Receives Grant

September 16, 2015 4:16 PM

TORONTO, ON / ACCESSWIRE / September 16, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it has entered into a collaboration with Dr. Leyla Soleymani of the Biointerfaces Institute of McMaster University and received an Engage Grant from NSERC (Natural Sciences and Engineering Research Council of Canada) to further...

Read more

ChroMedx Reports Testing of Key HemoPalm Analyzer Component

September 8, 2015 4:30 PM

TORONTO, ON / ACCESSWIRE / September 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that testing has commenced on the key spectroscopic component of the Analyzer of HemoPalm(TM) blood analysis device. The spectroscopic analysis of blood samples is a key aspect of the HemoPalm system which significantly differentiates it...

Read more

ChroMedX Engages Polygenesis Corporation for Completion of HemoPalm(TM) Alpha

September 2, 2015 4:39 PM

TORONTO, ON / ACCESSWIRE / September 2, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of technology development and prototyping firm Polygenesis Corporation to continue the development of the HemoPalm(TM) biosensor array, a fundamental component of the HemoPalm(TM) system. Polygenesis will build on the initial...

Read more

ChroMedX Submits PCT Patent Application for HemoPalm(TM) Blood Analysis System

August 28, 2015 4:38 PM

TORONTO, ON / ACCESSWIRE / August 28, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a PCT (Patent Cooperation Treaty) Patent Application pertaining to the HemoPalm(TM) Cartridge and Analyzer system called "Joint Spectroscopic and Biosensor System for Point-of-Care Testing"...

Read more

True Leaf Secures Canada-Wide Distribution for New Hemp Chews for Pets

August 12, 2015 2:59 AM

VANCOUVER, BC / ACCESSWIRE / August 12, 2015 / True Leaf Medicine International Ltd. (CSE: MJ) has secured coast-to-coast distribution for its new Trueleafpet(TM) Hemp Chew product line to be launched this fall. Freedom Pet Supplies (Freedom) has agreed to service Ontario to Prince Edward Island and Anipet Animal Supplies Inc. (Anipet) will cover the western provinces. Both companies cover the entire Canadian pet specialty marketplace, servicing...

Read more

ChroMedX Corp. Announces OTCQB Listing

August 4, 2015 2:10 PM

TORONTO, ON / ACCESSWIRE / August 4, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (Frankfurt: EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that its common shares recently commenced trading on the OTCQB(R), under the symbol "MNLIF." Real-time quotes and market information on the Company are available at http://www.otcmarkets.com/stock/MNLIF/quote "We are very pleased to be...

Read more

Chlorine Institute Issues New Guidance on Estimating the Area Affected by a Chlorine Release

July 27, 2015 10:15 AM

ARLINGTON, VA / ACCESSWIRE / July 27, 2015 / As part of its ongoing efforts to encourage safety best practices and share the latest technical information, The Chlorine Institute (CI – www.chlorineinstitute.org) has issued a new version of Pamphlet 74 - Guidance On Estimating the Area Affected By A Chlorine Release. The new version, Edition 6 dated June, 2015, reflects CI's strong collaboration with the U.S. Department of Homeland...

Read more

Renowned Veterinarian and Veterinary Cannabinoid Expert Joins True Leaf

May 21, 2015 9:02 AM

VANCOUVER, BC / ACCESSWIRE / May 21, 2015 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA.F). One of North America's foremost holistic veterinarians and a world expert on cannabis and its medicinal benefits for pets is joining True Leaf Medicine International's advisory board, the company announced today. Dr. Robert Silver of Boulder, Colorado, will provide True Leaf with knowledge and guidance as it develops cannabinoid-based...

Read more

Amfil Technologies, Inc. Announces Shareholder Update on Audited Financial Statement Submission and Grozone Product Line Developments

May 12, 2015 9:07 PM

TORONTO, ON / ACCESSWIRE / May 12, 2015 / Amfil Technologies, Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE) Announces the Filing of a Form 15 followed by a voluntary 10k which includes two years audited financial statements covering year ended June 30th 2013 and June 30th 2014 with the U.S. Securities and Exchange Commission (SEC) in connection with the company's previously announced intentions to regain its fully reporting status. The company...

Read more

Amfil Technologies, Inc. Issues Shareholder Update on Audited Financial Statement Submission and Grozone Product Line Developments

May 12, 2015 7:12 PM

TORONTO, ON / ACCESSWIRE / May 12, 2015 / Amfil Technologies, Inc. (OTC Pink: AMFE) (PINKSHEETS: AMFE) Announces the Filing of a Form 15 followed by a voluntary 10k which includes two years audited financial statements covering year ended June 30th 2013 and June 30th 2014 with the U.S. Securities and Exchange Commission (SEC) in connection with the company's previously announced intentions to regain its fully reporting status. The company...

Read more

Brenntag North America's David Garner Named Chlorine Institute 2015 Peter Mayo Award Honoree

April 15, 2015 7:43 PM

HOUSTON, TX / ACCESSWIRE / April 15, 2015 / David Garner, Senior Vice President, Operations for Brenntag North America, Inc. in Reading, PA, received The Chlorine Institute's 2015 Peter M. Mayo Award today at the Institute's Annual Meeting in Houston.  In 2004, The Chlorine Institute (CI) created the Peter M. Mayo award to recognize an individual for service and safety leadership in the chlorine industry through participation in The...

Read more

Top North American Safety Performance Facilities Receive Chlorine Institute 2015 Chairman's Safety Excellence Award

April 15, 2015 5:52 PM

HOUSTON, TX / ACCESSWIRE / April 15, 2015 / A select group of 33 North American chlor-alkali producers and packagers and bleach manufacturers received the prestigious Chlorine Institute (CI) Chairman's Safety Excellence Award at the Institute’s 2015 Annual Meeting today, reflecting the industry's long-standing commitment to continuous safety performance and improvement. Three facilities in Asia, Europe and South America also were...

Read more

Hybrid Signs Agreement with Fortune 500 Company - $20M Potential Revenue per Annum

April 7, 2015 8:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / April 7, 2015 / Hybrid Coating Technologies Inc. (OTCQB: HCTI) is pleased to announce that it has recently entered into an agreement with a Fortune 500 company to modify and then commercialize one of its products based on its non-isocyanate polyurethane platform technology. Upon successful completion of the product modifications, Hybrid will co-own any new patents based on these modifications with this partner...

Read more

Nivo Media Group Announces Management of LA's Totally Awesome Social Media Accounts and Website Launch

April 2, 2015 3:00 AM

LOS ANGELES, CA / ACCESSWIRE / April 2, 2015 / Nivo Media Group announced today that they will be managing the social media accounts and online presence for LA's Totally Awesome, the largest household goods manufacturer in the U.S. Nivo recently launched their new website, handling their website construction, UX design and all product photography. LA's Totally Awesome was founded by LD Hardas in 1983 after earning his Master's Degree in chemical...

Read more

ChroMedX Welcomes Dr. Nick Smit to Biosensor Development Team

March 25, 2015 4:56 PM

TORONTO, ON / ACCESSWIRE / March 25, 2015 / ChroMedX Corp. (CSE: CHX) (PINKSHEETS: MNLIF) (Frankfurt: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the engagement of Dr. Nick Smit as part of the HemoPalm biosensor development team.  Dr. Nick Smit received his Ph.D. in Analytical Chemistry from the University of Delaware and began his career at i-Stat in Princeton, New...

Read more

ChroMedX Appoints Dr. Robert Smyth to Technical Advisory Board

March 24, 2015 4:17 PM

TORONTO, ON / ACCESSWIRE / March 24, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce the appointment of anesthesiologist Dr. Robert Smyth to the Company's Technical Advisory Board.Dr. Smyth completed his MD from the University of Calgary and his anesthesia residency at the University of Toronto.  He is an...

Read more

ChroMedX Collaborates with Microfluidic and Microfabrication Experts for HemoPalm Cartridge Development

March 23, 2015 4:39 PM

TORONTO, ON / ACCESSWIRE / March 23, 2015 / ChroMedX Corp. (CSE: CHX) (PINKSHEETS: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce it has entered into a collaboration with Dr. Ravi Selvaganapathy of McMaster University to assist in the design and development of prototype cartridges for the Company's patented HemoPalm blood analyzer system. The McMaster and ChroMedX...

Read more

ChroMedX Submits US Provisional Patent Application for Recently Developed Aspects of HemoPalm Blood Analysis System

March 10, 2015 3:30 PM

TORONTO, ON / ACCESSWIRE / March 10, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a second US Provisional Patent Application pertaining to the HemoPalm Cartridge and Analyzer system.The second US Provisional Patent Application No. 62/114,700 entitled "Joint Spectroscopic and Biosensor System for...

Read more